CORT
Corcept Therapeutics Incorporated · Healthcare · Medical - Pharmaceuticals
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +10 | 52.54M | $4.56B | +17 | −6 |
| Q1 2026 | 107 | -4 | 51.80M | $2.09B | +8 | −13 |
| Q4 2025 | 112 | 0 | 56.18M | $1.96B | +1 | — |
| Q3 2025 | 18 | -2 | 41.55M | $3.45B | +1 | −4 |
| Q2 2025 | 18 | +1 | 38.50M | $2.83B | +1 | — |
| Q1 2025 | 14 | +1 | 15.71M | $1.80B | +1 | — |
| Q4 2024 | 13 | 0 | 16.40M | $826.20M | — | — |
| Q3 2024 | 12 | -1 | 13.66M | $632.44M | — | −1 |
| Q2 2024 | 13 | — | 13.78M | $447.82M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 6.91M | — | $224.59M | 0.4% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasif) | 2.28M | — | $74.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 2.28M | — | $74.07M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Arrowstreet Capital ✦ | 1.48M | — | $48.20M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 949.14K | — | $30.84M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 949.14K | — | $30.84M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Norges Bank ✦ (pasif) | 822.12K | — | $26.71M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Two Sigma Investments ✦ | 393.78K | — | $12.79M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 302.30K | — | $9.82M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 259.65K | — | $8.44M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 259.65K | — | $8.44M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 239.06K | — | $7.77M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 239.06K | — | $7.77M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 239.06K | — | $7.77M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 51.13K | — | $1.66M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Wellington Management ✦ | 45.26K | — | $1.47M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Wellington Management ✦ | 45.26K | — | $1.47M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Wellington Management ✦ | 45.26K | — | $1.47M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Wellington Management ✦ | 45.26K | — | $1.47M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 24.95K | — | $810,788 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 20.20K | — | $656,298 | 0.0% | n/c | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 347 pemegang, 79.01M saham, $2.83B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 4.98K lbr · $585,478
Director · 91.17K lbr · $10.78M
Director · 7.05K lbr · $838,710
Director · 400 lbr · $47,855
Officer · 10.00K lbr · $1.16M
Director · 3.05K lbr · $337,341
Director · 4.67K lbr · $520,214
Director · 2.28K lbr · $256,706
Officer · 3.66K lbr · $419,491
Officer · 11.53K lbr · $1.30M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi